Edition:
United States

India Globalization Capital Inc (IGC.A)

IGC.A on American Stock Exchange

0.41USD
4:00pm EDT
Change (% chg)

$0.01 (+1.32%)
Prev Close
$0.41
Open
$0.45
Day's High
$0.45
Day's Low
$0.40
Volume
24,585
Avg. Vol
35,132
52-wk High
$0.80
52-wk Low
$0.19

IGC.A

Chart for IGC.A

About

India Globalization Capital, Inc. develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. The Company also builds farming facilities for leasing. In Malaysia, the Company develops and manages residential and... (more)
No analyst recommendations are available for IGC.A.

Overall

Beta: 2.33
Market Cap(Mil.): $11.31
Shares Outstanding(Mil.): 27.61
Dividend: --
Yield (%): --

Financials

  IGC.A Industry Sector
P/E (TTM): -- 142.93 17.37
EPS (TTM): -0.12 -- --
ROI: -18.38 2.34 -5.89
ROE: -24.55 0.22 -5.30

BRIEF-Ram Mukunda reports a 13.96 pct stake in India Globalization Capital

* Ram Mukunda reports a 13.96 percent stake in India Globalization Capital Inc as of May 9 - SEC filing Source text for Eikon: (http://bit.ly/2pEJg2e) Further company coverage:

May 12 2017

BRIEF-India Globalization Capital files for patent applications for IGC-501 in Canada, Israel and Europe

* Has filed patent applications for IGC-501 in Canada, Israel, and Europe Source text for Eikon: Further company coverage:

Apr 10 2017

BRIEF-IGC sells Malaysian hotel investment interest

* Has sold its ten percent holding in Brilliant Hallmark for a consideration of four million shares of co

Apr 05 2017

BRIEF-IGC launches phytocannabinoid development committee to secure preclinical initiatives for IGC-501, IGC-502, IGC-504

* India Globalization Capital Inc - IGC launches phytocannabinoid development committee to secure preclinical initiatives for IGC-501, IGC-502, IGC-504 Source text for Eikon: Further company coverage:

Feb 13 2017

More From Around the Web

Earnings vs. Estimates